Terms: = Breast cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb AND Treatment
37 results:
1. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.
Lin CJ; Jin X; Ma D; Chen C; Ou-Yang Y; Pei YC; Zhou CZ; Qu FL; Wang YJ; Liu CL; Fan L; Hu X; Shao ZM; Jiang YZ
Cancer Cell; 2024 Apr; 42(4):701-719.e12. PubMed ID: 38593782
[TBL] [Abstract] [Full Text] [Related]
2. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract] [Full Text] [Related]
3. Solid basal adenoid cystic carcinoma of the breast: A case report and literature review.
Gou WB; Yang YQ; Song BW; He P
Medicine (Baltimore); 2024 Jan; 103(3):e37010. PubMed ID: 38241532
[TBL] [Abstract] [Full Text] [Related]
4. Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer.
Pascual-Reguant L; Serra-Camprubí Q; Datta D; Cianferoni D; Kourtis S; Gañez-Zapater A; Cannatá C; Espinar L; Querol J; García-López L; Musa-Afaneh S; Guirola M; Gkanogiannis A; Miró Canturri A; Guzman M; Rodríguez O; Herencia-Ropero A; Arribas J; Serra V; Serrano L; Tian TV; Peiró S; Sdelci S
EMBO Mol Med; 2023 Dec; 15(12):e18459. PubMed ID: 37937685
[TBL] [Abstract] [Full Text] [Related]
5. Solid-Basaloid Adenoid Cystic Carcinoma of the breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With myb Overexpression.
Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
[TBL] [Abstract] [Full Text] [Related]
6. A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle.
Li Y; Zhao D; Zhang W; Yang M; Wu Z; Shi W; Lan S; Guo Z; Yu H; Wu D
J Transl Med; 2023 Jun; 21(1):422. PubMed ID: 37386467
[TBL] [Abstract] [Full Text] [Related]
7. A novel mutant PIK3R1
Wang K; Hu Y; Xu L; Zhao S; Song C; Sun S; Li X; Li M
Mol Biol Rep; 2022 Jul; 49(7):6155-6160. PubMed ID: 35384625
[TBL] [Abstract] [Full Text] [Related]
8. Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects.
Albert V; Piendl G; Yousseff D; Lammert H; Hummel M; Ortmann O; Jagla W; Gaumann A; Wege AK; Brockhoff G
Arch Gynecol Obstet; 2022 Oct; 306(4):1197-1210. PubMed ID: 35298675
[TBL] [Abstract] [Full Text] [Related]
9. Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.
Loo SK; Yates ME; Yang S; Oesterreich S; Lee AV; Wang XS
Genes Chromosomes Cancer; 2022 May; 61(5):261-273. PubMed ID: 35106856
[TBL] [Abstract] [Full Text] [Related]
10. Genomic Characterization of
Garrido-Castro AC; Spurr LF; Hughes ME; Li YY; Cherniack AD; Kumari P; Lloyd MR; Bychkovsky B; Barroso-Sousa R; Di Lascio S; Jain E; Files J; Mohammed-Abreu A; Krevalin M; MacKichan C; Barry WT; Guo H; Xia D; Cerami E; Rollins BJ; MacConaill LE; Lindeman NI; Krop IE; Johnson BE; Wagle N; Winer EP; Dillon DA; Lin NU
Clin Cancer Res; 2021 Feb; 27(4):1105-1118. PubMed ID: 33293374
[TBL] [Abstract] [Full Text] [Related]
11. The role of myb proto-oncogene like 2 in tamoxifen resistance in breast cancer.
Li X; Zhang X; Wu CC; Li PP; Fu YM; Xie LH; Sun SS; Zhou YY; Zhu BL
J Mol Histol; 2021 Feb; 52(1):21-30. PubMed ID: 33141360
[TBL] [Abstract] [Full Text] [Related]
12. mybL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential.
Bayley R; Ward C; Garcia P
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188407. PubMed ID: 32853735
[TBL] [Abstract] [Full Text] [Related]
13. Cisplatin sensitivity in breast cancer cells is associated with particular DMTF1 splice variant expression.
Niklaus NJ; Humbert M; Tschan MP
Biochem Biophys Res Commun; 2018 Sep; 503(4):2800-2806. PubMed ID: 30100063
[TBL] [Abstract] [Full Text] [Related]
14. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
[TBL] [Abstract] [Full Text] [Related]
15. Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-myb and FOXM1 in breast cancer cell lines and are potential targets for therapy.
Wolter P; Hanselmann S; Pattschull G; Schruf E; Gaubatz S
Oncotarget; 2017 Feb; 8(7):11160-11172. PubMed ID: 28061449
[TBL] [Abstract] [Full Text] [Related]
16. CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of myb and MCL-1 expression.
Mitra P; Yang RM; Sutton J; Ramsay RG; Gonda TJ
Oncotarget; 2016 Feb; 7(8):9069-83. PubMed ID: 26812885
[TBL] [Abstract] [Full Text] [Related]
17. New Insights on COX-2 in Chronic Inflammation Driving breast cancer Growth and Metastasis.
Hugo HJ; Saunders C; Ramsay RG; Thompson EW
J Mammary Gland Biol Neoplasia; 2015 Dec; 20(3-4):109-19. PubMed ID: 26193871
[TBL] [Abstract] [Full Text] [Related]
18. B-myb is a gene implicated in cell cycle and proliferation of breast cancer.
Tao D; Pan Y; Lu H; Zheng S; Lin H; Fang H; Cao F
Int J Clin Exp Pathol; 2014; 7(9):5819-27. PubMed ID: 25337223
[TBL] [Abstract] [Full Text] [Related]
19. Epithelial and stromal microRNA signatures of columnar cell hyperplasia linking Let-7c to precancerous and cancerous breast cancer cell proliferation.
Björner S; Fitzpatrick PA; Li Y; Allred C; Howell A; Ringberg A; Olsson H; Miller CJ; Axelson H; Landberg G
PLoS One; 2014; 9(8):e105099. PubMed ID: 25122196
[TBL] [Abstract] [Full Text] [Related]
20. Estrogen induces Vav1 expression in human breast cancer cells.
Du MJ; Chen XD; Zhou XL; Wan YJ; Lan B; Zhang CZ; Cao Y
PLoS One; 2014; 9(6):e99052. PubMed ID: 24905577
[TBL] [Abstract] [Full Text] [Related]
[Next]
